Cipla Limited
Cipla Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: CIPLA and BSE: 500087 (ISIN INE059A01026).
It has a market capitalisation of ₹1.07 lakh crore, a last close of ₹1,324 on 2026-10-19, a one-year return of -16.1%.
Valuation: a price-to-earnings ratio of 31.73x, a price-to-book ratio of 3.11x, a dividend yield of 1.0%.
Profitability: return on equity of 11.8%, return on capital employed of 15.7%, an operating margin of 18.7%.
Growth: sales growth of 7.4% a year over three years, net profit growth of 11.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x, promoter holding of 29.2%.
| Metric | Value |
|---|---|
| Market capitalisation | 1.07 L Cr |
| Last close | ₹1,324 |
| P/E (TTM) | 31.73x |
| P/B | 3.11x |
| Dividend yield | 1.0% |
| ROE (FY) | 11.8% |
| ROCE (FY) | 15.7% |
| Operating margin (TTM) | 18.7% |
| Sales growth, 3-year CAGR | 7.4% |
| Profit growth, 3-year CAGR | 11.5% |
| Debt / equity | 0.01x |
| Promoter holding | 29.2% |
| 1-year return | -16.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means